Astrazeneca reported $387M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Astrazeneca AZN:US USD 387M 0
AstraZeneca AZN:LN USD 387M 0
Bristol Myers Squibb BMY:US USD 292M 0
Canopy Growth Corp WEED:CN CAD 7.82B 216.52M
Catalent CTLT:US USD 2M 0
Corcept Therapeutics CORT:US USD 130K 2K
Eli Lilly And LLY:US USD 594.1M 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
Genmab GEN:DC DKK 66M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Horizon Pharma HZNP:US USD 23K 0
Lannett LCI:US USD 43K 1000
Novartis NOVN:VX USD 878.25M 11.75M
Pacira Pharmaceuticals PCRX:US USD 46K 0
Perrigo Ordinary Shares PRGO:US USD 6.96B 27.4M
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 547K 0
Roche Holding ROG:VX 107M 53M
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Valeant Pharmaceuticals VRX:CN USD 10.39B 7M
Zoetis ZTS:US USD 5M 0